middle.news
Vitrafy targets FDA listing as Guardion fleet reaches 19 devices
12:27pm on Tuesday 17th of November, 2026 AEDT
•
Life Sciences
Read Story
Vitrafy targets FDA listing as Guardion fleet reaches 19 devices
12:27pm on Tuesday 17th of November, 2026 AEDT
Key Points
19 Guardion devices built, including nine in the first quarter of FY27
FDA Class II medical device listing expected in the coming weeks
US partnerships now span blood, cell and gene therapy
$38.3 million in cash and term deposits at 30 September
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Vitrafy Life Sciences (ASX:VFY)
OPEN ARTICLE